NCT06007404
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
At risk: Primary completion moved at least 31 days later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary endpoints: details revised at 1 of 5 entries
- Primary completion pushed from Oct 2026 to Dec 2026
- Eligibility criteria shortened, about 10 words
- Secondary endpoints: details revised at 2 of 2 entries
- Minor Primary completion moved earlier from Sep 2027 to Oct 2026v6
- Minor Eligibility criteria expanded, about 9 words
- Study arms: 4 to 5
- Minor Eligibility criteria expanded, about 27 words
- Study arms: 3 to 4
- Minor Start date changed from estimate of Sep 2023 to Sep 6, 2023v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Glucose (OGTT)
Timeframe: 120 minutes
Insulin (OGTT)
Timeframe: 120 minutes
Glucose (MMTT)
Timeframe: 180 minutes
Insulin (MMTT)
Timeframe: 180 minutes
Monocyte /macrophage populations by flow cytometry
Timeframe: 180 minutes
Secondary (2)
Free fatty acids (MMTT)
Triglycerides (MMTT)
Arms and interventions
Normal weight
BMI ≥ 5th percentile \& \< 85th percentile
Obese weight
BMI ≥ 95th percentile
PreDiabetes
HbA1c \> 5.7%
Type 2 Diabetes
Diagnosed with Type 2 Diabetes
Overweight
BMI \> 86th percentile and \<94th percentile
Sites
1 site in 1 country
- University of MichiganAnn Arbor, Michigan, United States